Cadrenal Therapeutics, Inc. Quarterly Depreciation in USD from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cadrenal Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2022 to Q2 2024.
  • Cadrenal Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $470.000, a 21.3% decline year-over-year.
  • Cadrenal Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $2.26K.
  • Cadrenal Therapeutics, Inc. annual Depreciation for 2023 was $1.98K, a 56.4% increase from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.26K $470 -$127 -21.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $2.39K $597 +$407 +214% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.98K $596 Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $597 +$91.00 +18% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $597 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $190 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $506 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.